SIGN UP
LOG IN
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Benzinga·10/11/2022 21:57:18
Listen to the news
Gainers
- Adamis Pharmaceuticals (NASDAQ:ADMP) stock rose 41.7% to $0.21 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 1.8 million shares, which is 219.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $31.1 million.
- OpGen (NASDAQ:OPGN) shares moved upwards by 18.26% to $0.25. The market value of their outstanding shares is at $13.2 million.
- Kiora Pharmaceuticals (NASDAQ:KPRX) stock rose 11.98% to $8.41. The company's market cap stands at $7.7 million.
- InVivo Therapeutics Hldg (NASDAQ:NVIV) shares rose 11.34% to $3.73. The company's market cap stands at $5.1 million.
- SCWorx (NASDAQ:WORX) stock rose 10.05% to $0.76. The company's market cap stands at $9.7 million.
- Applied Genetic Techs (NASDAQ:AGTC) shares rose 9.03% to $0.26. The company's market cap stands at $17.7 million.
Losers
- Revelation Biosciences (NASDAQ:REVBU) shares fell 18.6% to $0.3 during Tuesday's after-market session.
- BiondVax Pharmaceuticals (NASDAQ:BVXV) stock declined by 9.81% to $0.6. The company's market cap stands at $11.2 million.
- HTG Molecular Diagnostics (NASDAQ:HTGM) shares decreased by 8.46% to $0.54. The market value of their outstanding shares is at $5.9 million.
- Sesen Bio (NASDAQ:SESN) shares declined by 8.1% to $0.47. The market value of their outstanding shares is at $93.2 million.
- Universe Pharmaceuticals (NASDAQ:UPC) shares decreased by 6.6% to $0.85. The market value of their outstanding shares is at $18.4 million.
- Viking Therapeutics (NASDAQ:VKTX) stock fell 5.11% to $2.79. The market value of their outstanding shares is at $213.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.